Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
34
XTNT Quote, Financials, Valuation and Earnings
Last price:
$0.64
Seasonality move
:
-3.57%
Day range:
$0.59 - $0.67
52-week range:
$0.33 - $0.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.69x
P/B ratio:
1.97x
Volume:
137.7K
Avg. volume:
83.3K
1-year change:
-20.46%
Market cap:
$86.4M
Revenue:
$117.3M
EPS (TTM):
-$0.09
Earnings Data
Next earnings date for XTNT
Aug 08
2025
Most recent earnings per share
--
Beat by $0.01
(May 12/2025)
Consensus Estimate
-$0.01
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
XTNT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $31.2M | -- | -- | -$0.01 | -- |
| 08/08/2025 | Q2 | $31.4M | -- | -- | -$0.02 | -- |
| 05/12/2025 | Q1 | $31.2M | $32.9M | -- | -$0.01 | -- |
| 03/06/2025 | Q4 | $31.8M | $31.5M | -$0.02 | -$0.02 | -- |
| 11/12/2024 | Q3 | $29.3M | $27.9M | -$0.04 | -- | -- |
| 08/08/2024 | Q2 | $28.7M | $29.9M | -$0.03 | -$0.02 | -$0.01 |
| 05/15/2024 | Q1 | $25.8M | $27.9M | -$0.03 | -$0.02 | -$0.01 |
| 03/07/2024 | Q4 | $26.6M | $28.1M | -$0.03 | -$0.02 | -$0.01 |
| 11/09/2023 | Q3 | -- | -- | $0.07 | -$0.01 | $0.08 |
| 08/01/2023 | Q2 | -- | -- | -$0.02 | -$0.02 | -- |
| 05/04/2023 | Q1 | -- | -- | -$0.02 | -$0.03 | $0.01 |
| 03/07/2023 | Q4 | -- | -- | -$0.02 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$0.03 | -- | -- |
| 08/04/2022 | Q2 | -- | -- | -$0.02 | -- | -- |
| 05/05/2022 | Q1 | -- | -- | -$0.03 | -- | -- |
| 03/08/2022 | Q4 | -- | -- | -$0.03 | -- | -- |
| 11/12/2021 | Q3 | -- | -- | -$0.02 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$0.01 | -- | -- |
| 05/11/2021 | Q1 | -- | -- | -$0.00 | -- | -- |
| 02/24/2021 | Q4 | -- | -- | -$0.01 | -- | -- |
| 10/29/2020 | Q3 | -- | -- | -$0.10 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.19 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.19 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.14 | -- | -- |
| 04/02/2018 | Q1 | -- | -- | -$0.54 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$5.60 | $2.16 | -$7.76 |
| 09/30/2017 | Q3 | -- | -- | -$5.64 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$6.18 | -$1.20 | -$4.98 |
Xtant Medical Holdings Earnings Questions
-
How Much did Xtant Medical Holdings Generate in Revenue Last Quarter?
Xtant Medical Holdings reported $32.9M worth of top line sales in its most recent quarter.
-
Did Xtant Medical Holdings Beat Earnings Last Quarter?
Xtant Medical Holdings announced earnings per share of -- which represents a beat of analyst forecast a -$0.01 per share.
-
Is Xtant Medical Holdings Profitable?
Xtant Medical Holdings reported $20.2M that represents $0.14 per share over the last quarter.
-
What is the Analyst Consensus for Xtant Medical Holdings EPS Next Year?
Xtant Medical Holdings's earnings are forecast to decrease from -$0.12 per share to -$0.12 per share next year representing a decrease of -75%.
-
When is Xtant Medical Holdings's Earnings Date?
Xtant Medical Holdings's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 1.39% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 6.35% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 5.29% over the past day.
